Alx Oncology Holdings (ALXO) Interest & Investment Income (2020 - 2026)
Alx Oncology Holdings (ALXO) posted Interest & Investment Income of $1.2 million for Q1 2026, up 106.28% sequentially from $573000.0 in Q4 2025, and down 20.3% YoY from $1.5 million in Q1 2025.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Interest & Investment Income (2020 - 2026) Analysis & Trends
Alx Oncology Holdings has reported Interest & Investment Income for 5 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Interest & Investment Income fell 20.3% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 55.51% YoY) and the FY2025 annual result came in at $4.0 million, down 57.68% from the prior year.
- Interest & Investment Income advanced to $1.2 million in Q1 2026 per ALXO's latest filing, from $573000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.0 million in Q4 2023 and troughed at -$650000.0 in Q2 2022.
- A 5-year average of $937411.8 and a median of $802000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income tumbled 130.12% in 2024, then jumped 750.44% in 2025.
- Over 5 years, Interest & Investment Income stood at $1.8 million in 2022, then soared by 65.74% to $3.0 million in 2023, then tumbled by 37.3% to $1.9 million in 2024, then plunged by 69.49% to $573000.0 in 2025, then surged by 106.28% to $1.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1.2 million, $573000.0, and $802000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Alx Oncology Holdings | 274.67 Mn | 274.67 Mn | - | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | -273,000.00 |
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 802,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | -157,000.00 |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | -228,000.00 |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | -224,000.00 |
| Mar 31, 2023 | 757,000.00 |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | -650,000.00 |
| Mar 31, 2022 | -606,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 22,000.00 |